Overview

Effect of Etoricoxib to Treat Chronic Low Back Pain (0663-041)

Status:
Completed
Trial end date:
2000-11-01
Target enrollment:
Participant gender:
Summary
Study the effect of etoricoxib 60 mg and 90 mg compared to placebo to treat chronic low back pain.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Etoricoxib